Multiple milestones anticipated from late-stage portfolio including topline results from DIAMOND Phase 3 trials with OCS-01 ...
More than 1 in 3 people globally are affected by neurological conditions, making neurological disorders the leading cause of disability and second leading cause of death worldwide.¹ Neurological ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback